Core Viewpoint - The recent semi-annual adjustment of the FTSE Global Equity Index Series has included several Hong Kong stocks, indicating a shift in market dynamics and highlighting the performance of certain sectors, particularly gold and biopharmaceuticals [1][2][3]. Group 1: Index Adjustments - Chifeng Jilong Gold Mining (06693) and Laopuhuang Gold (06181) have been included in the FTSE China Large Cap Index for the first time, while 11 Hong Kong stocks, including SF Express (09699) and SOTY Technology (02498), have been added to the FTSE China Small Cap Index [1][2]. - The FTSE Global Equity Index Series categorizes stocks into four market capitalization tiers based on free float market capitalization, which excludes strategic holdings and locked shares [1]. Group 2: Market Performance - The newly included stocks have shown significant price increases this year, with Chifeng Jilong Gold rising over 120% and Laopuhuang Gold increasing by over 200%, reflecting strong sector performance [3]. - The biopharmaceutical sector has also seen substantial growth, with companies like Rongchang Bio (09995) and Sanofi (01530) experiencing stock price increases of nearly 670% and a market capitalization exceeding 77 billion HKD, respectively [3][5]. Group 3: Company Highlights - Chifeng Jilong Gold focuses on gold mining and resource recovery, reporting a net profit of 1.107 billion RMB in the first half of 2025, a year-on-year increase of 55.79% [4]. - Laopuhuang Gold, which went public on June 28, 2024, has seen its stock price surge by 204.65% this year, making it the highest-priced stock in the Hong Kong market [4]. - SF Express, as the largest third-party instant delivery platform in China, has seen steady growth in market capitalization and liquidity since its listing in December 2021, with a target price of 20 HKD set by Daiwa [4]. - Sanofi has gained attention due to a significant business development deal with Pfizer, leading to a market capitalization of 77 billion HKD [5]. - Fourth Paradigm (06682) has received positive outlooks from multiple brokerages, with target prices raised due to its strong position in the AI sector [6].

Core Viewpoint - FTSE Russell has updated its semi-annual adjustment list for the FTSE Global Equity Index Series, with several Hong Kong stocks being included in the FTSE China Large Cap and Small Cap indices, effective after the market close on September 19 [1][2]. Group 1: Index Adjustments - Chifeng Jilong Gold Mining (06693) and Laopu Gold (06181) are newly included in the FTSE China Large Cap Index, marking their first inclusion [1]. - Eleven Hong Kong stocks, including SF Express (09699) and SOTY Technology (02498), have been added to the FTSE China Small Cap Index [1][2]. - The adjustments reflect a focus on companies with large market capitalization and high liquidity, indicating a strategic selection of industry leaders [1]. Group 2: Market Performance - The newly included stocks have shown significant price increases this year, outperforming the broader market, with Chifeng Jilong Gold Mining rising over 120% and Laopu Gold increasing by over 200% [3]. - The biopharmaceutical sector has also seen strong performance, with companies like Rongchang Biopharmaceutical (09995) and 3SBio (01530) experiencing substantial stock price increases, with Rongchang Biopharmaceutical rising nearly 670% [3]. Group 3: Company Highlights - Chifeng Jilong Gold Mining reported a net profit of 1.107 billion RMB for the first half of 2025, a year-on-year increase of 55.79%, benefiting from a bullish gold market [4]. - Laopu Gold, which went public on June 28, 2024, has seen its stock price soar by 204.65% this year, making it the highest-priced stock in the Hong Kong market [4]. - SF Express has established itself as a leading third-party instant delivery platform, with a stable increase in market capitalization and liquidity since its listing in December 2021 [4]. Group 4: Future Outlook - The inclusion in international indices is expected to attract more capital and enhance liquidity for the newly added companies, potentially leading to further stock price support [3]. - Companies like 3SBio and Fourth Paradigm (06682) are anticipated to benefit from their strong market positions and growth potential in their respective sectors, with analysts raising target prices for these stocks [5][6].

Group 1 - FTSE Russell updated its FTSE Global Equity Index Series, including companies like SF Express and others into the FTSE China Small Cap Index, effective after market close on September 19 [1] - A total of 89 Chinese stocks were included in the small-cap index, with 14 being Hong Kong stocks, highlighting the recognition of their comprehensive strength and development potential in the international capital market [1] - SF Express, as the largest third-party instant delivery platform in China, has seen steady growth in market capitalization and liquidity since its listing in December 2021, solidifying its leading position in the industry [1] Group 2 - Inclusion in international indices typically leads to increased capital attention and liquidity premium, potentially attracting more incremental funds and enhancing trading activity for the company [2] - SF Express has also been included in multiple indices, such as MSCI China Small Cap Index and Hang Seng Composite Index, indicating ongoing recognition in mainstream international capital markets [2] - Financial performance has improved significantly, with revenue reaching 10.236 billion yuan, a 48.8% year-on-year increase, and net profit growing by 120.4% to 137 million yuan, marking a historical high [2] - The growth in performance is attributed to the rapid development of the food delivery and instant retail sectors, with a more than 50% year-on-year increase in same-city delivery order volume [2] - The company is expected to continue benefiting from deepening relationships with key accounts, expansion in mid-tier markets, and penetration into lower-tier markets [2]

Group 1 - Shenzhen SF Intelligent Technology Co., Ltd. was established on September 17, with a registered capital of 10 million yuan [1] - The legal representative of the company is Chen Xiwen, and its business scope includes research and development of intelligent robots, artificial intelligence public data platforms, and basic software development for artificial intelligence [1] - The company is wholly owned by SF Express (09699.HK) [1]

Core Insights - The express delivery industry is entering a new phase of accelerated development, with delivery riders becoming an essential part of the urban commercial ecosystem, leading to increased demands for career development, life security, and social recognition [1][15] - SF Express aims to enhance the delivery experience and provide more professional recognition for riders through initiatives announced at the 7th Knight Festival [1][3] Group 1: Career Development and Support - SF Express has established a more comprehensive promotion system for riders, providing personalized career development support and creating broader opportunities for those with aspirations [6][7] - The company announced an investment of 30 million yuan in a Dream Fund to support projects like the "Dream Plan" and "Emotional Care," which includes skills training and educational subsidies for riders [7][9] - As of August 2025, over 1,700 riders have been promoted to team leaders, with a year-on-year increase of 60.1% in the number of team leaders [6][7] Group 2: Health and Well-being - The health risks faced by riders are significant, with data indicating that their risk of cardiovascular diseases is three times higher than that of regular office workers, and 58% suffer from lumbar issues [10] - SF Express has launched a health movement plan in collaboration with a health platform to provide scientific training courses and recovery guidance, aiming to improve riders' physical well-being [10][12] - The company has also partnered with medical services to provide health memberships for 7,000 riders, shifting health management from reactive to proactive support [10] Group 3: Financial and Emotional Support - Many riders bear the dual responsibilities of being family economic supporters and educators, with over 60% of local riders having children, which drives their work motivation [9][15] - SF Express has improved operational efficiency and order management, resulting in a 38% year-on-year increase in rider productivity and a 107% increase in the number of riders earning over 10,000 yuan monthly [9] - The company has established an emotional support mechanism, including a "Care Fund" that has processed 78,000 cases and provided 4.2 million yuan in assistance, addressing riders' emotional and financial needs [14]

Group 1 - Shenzhen SF Intelligent Technology Co., Ltd. has been established with a registered capital of 10 million yuan, focusing on the development of intelligent robots, AI public data platforms, and AI software [1] - The company is wholly owned by SF Express (09699.HK) [1] Group 2 - Food and Beverage ETF (Product Code: 515170) tracks the China Securities Food and Beverage Industry Theme Index, with a recent five-day decline of 1.63% and a price-to-earnings ratio of 21.12 times [3] - Gaming ETF (Product Code: 159869) tracks the China Securities Animation and Gaming Index, showing a five-day increase of 4.78% and a price-to-earnings ratio of 46.35 times [4] - Cloud Computing 50 ETF (Product Code: 516630) tracks the China Securities Cloud Computing and Big Data Theme Index, with a five-day increase of 9.47% and a price-to-earnings ratio of 121.53 times [5]

Group 1 - Shenzhen SF Intelligent Technology Co., Ltd. has been established with a registered capital of 10 million yuan [1] - The company's business scope includes research and development of intelligent robots, artificial intelligence public data platforms, and development of artificial intelligence basic software and theoretical algorithms [1] - SF Intelligent Technology is wholly owned by SF Express (09699.HK) [1]

Core Insights - The third-party instant delivery platform, SF Express's local subsidiary, has officially launched its "SoFast" brand in Macau, marking a significant expansion following its entry into Hong Kong last year [1] - SF Express has formed a strategic partnership with Macau's largest local service platform, "Aomi App," to enhance resource integration and provide efficient, convenient one-stop delivery services for local merchants and users [1] - The "SoFast" service will cover a wide range of categories, including food and non-food items, with delivery times as fast as one hour, utilizing multiple channels such as "Aomi App" and "SF-EXPRESS App" [1][2] Business Model and Market Potential - Merchants in Macau can place orders through the SF Express merchant version, while consumers can access the service via "Aomi App" or "SF-EXPRESS App," catering to the growing demand for instant delivery in the region [2] - The demand for rapid and timely delivery services in Macau has been increasing, indicating significant growth potential in the instant delivery market compared to mainland China [2] - SF Express aims to leverage its successful experience in mainland China to enhance its service offerings in Macau and the broader Hong Kong-Macau region, integrating more merchant brands and expanding its user services [2] Future Opportunities - The experience gained in the Greater Bay Area is expected to lay a solid foundation for the company's future expansion into other overseas markets [3]

Group 1 - The Hang Seng Index rose by 0.07%, gaining 19 points to close at 26,465 points, while the Hang Seng Tech Index increased by 0.39% [1] - The early trading volume in Hong Kong stocks reached 160.2 billion HKD [1] Group 2 - New pharmaceutical stocks in the Hong Kong Stock Connect saw significant gains, with ZhiJie AnKang-B (02617) surging over 49%, reaching a market capitalization of over 240 billion HKD; BaiZe Medical (02609) rose over 76%; and TongYuanKang Pharmaceutical-B (02410) increased by over 36% [1] - Fosen Pharmaceutical (01652) experienced a dramatic rise of over 410%, closing at 1.35 HKD, up 297%, following the approval of Metformin and Ertugliflozin tablets [2] - Shanghai Fudan (01385) increased by 5.87%, with the company well-prepared for supply chain disruptions, and Morgan Stanley noted limited impact on demand [2] - SF Express (09699) rose over 6% as its "SoFast" service officially launched in Macau, with Daiwa optimistic about the company's revenue growth prospects [2] - Valiant Bio-B (09887) increased by over 13%, with its core product LBL-024 for melanoma completing its first patient dosing in trials [2] - Bilibili-W (09626) rose by 2.78%, accumulating a total increase of about 25% over the past six days, with the new game "Three Kingdoms: Hundred Generals" set for testing in October [2] - LionTeng Holdings (02562) surged over 7% as it plans to acquire leading companies in artificial intelligence and blockchain to expand its digital finance layout [2] - GCL-Poly Energy (03800) rose by 3.97%, planning a discounted placement to raise approximately 5.392 billion HKD for structural adjustments in polysilicon capacity [2] - China General Nuclear Power Corporation Mining (01164) increased by 6.7%, as the U.S. seeks to expand its strategic uranium reserves, with institutions expecting a recovery in uranium prices [2] - Yunfeng Financial (00376) fell over 16% after announcing a discounted placement to raise about 1.15 billion HKD [2]

Market Overview - The Hang Seng Index rose by 0.07%, gaining 19 points to close at 26,465 points, while the Hang Seng Tech Index increased by 0.39% [1] - Early trading volume in Hong Kong stocks reached HKD 160.2 billion [1] Notable Stock Movements - New pharmaceutical stocks in the Hong Kong Stock Connect surged, with Yaojie Ankang-B (02617) rising over 49%, reaching a market capitalization of over HKD 240 billion [1] - Baize Medical (02609) saw an increase of over 76% [1] - Tongyuan Kang Pharmaceutical-B (02410) rose by over 36% [1] Specific Company Highlights - Fosen Pharmaceutical (01652) experienced a dramatic rise of over 410%, closing at HKD 1.35, up 297%, following the approval of Metformin and Ertugliflozin tablets [2] - Shanghai Fudan (01385) increased by 5.87%, with the company prepared for supply chain disruptions, and Morgan Stanley noted limited impact on demand [2] - SF Express (09699) rose by over 6% as its "SoFast" service launched in Macau, with positive revenue growth prospects according to Daiwa [2] - Valiant Pharmaceuticals-B (09887) increased by over 13%, completing the first medication trial for its core product LBL-024 for melanoma [2] - Bilibili-W (09626) rose by 2.78%, accumulating a 25% increase over six days, with the new game "Three Kingdoms: Hundred Generals" set for testing in October [2] - Liontech Holdings (02562) surged over 7% as it plans to acquire a leading AI and blockchain company to expand its digital finance footprint [2] - GCL-Poly Energy (03800) rose by 3.97%, planning a discounted share placement to raise approximately HKD 5.392 billion for structural adjustments in polysilicon capacity [2] - CGN Mining (01164) increased by 6.7% amid expectations of rising uranium prices as the U.S. seeks to expand its strategic uranium reserves [2] - Yunfeng Financial (00376) fell over 16% after announcing a discounted share placement to raise about HKD 1.15 billion [2]